Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g  by McNamara, Patrick J. et al.
C
H
D
Congenital Heart Disease McNamara et alPatent ductus arteriosus ligation is associated with impaired left
ventricular systolic performance in premature infants weighing less
than 1000 gPatrick J. McNamara, MB Bch MRCPCH,a,b,c Lilian Stewart, MD,b Sandesh P. Shivananda, MD,b
Derek Stephens, MSc,c and Arvind Sehgal, MDbFrom Ph
search
trics,c
Disclosu
Dr Stew
Receive
public
Address
Child
patric
0022-52
Crown
Associa
doi:10.1
150Objective: Patent ductus arteriosus ligation is often complicated by systemic hypotension and oxygenation failure.
The ability of the immature myocardium to compensate for altered afterload is poorly understood. The aim of this
studywas to characterize the effects of patent ductus arteriosus ligationonmyocardial performance inpreterm infants.
Methods: Serial echocardiographic analysis was performed before and after patent ductus arteriosus ligation.
Characteristics of the patent ductus arteriosus, myocardial performance (fractional shortening, mean velocity
of circumferential fiber shortening, and left ventricular output) and left ventricular afterload (end-systolic wall
stress) were assessed. The stress–velocity relationship was measured as a preload-independent, afterload-adjusted
measure of myocardial contractility.
Results: Forty-six preterm infants were assessed at 28.5 11.3 days and a weight of 1058 272 g. Patent ductus
arteriosus ligation was followed by increased left ventricular exposed vascular resistance temporally coinciding
with reduced left ventricular preload, decreased left ventricular contractility, and low left ventricular output. Ne-
onates weighing 1000 g or less had a higher rate of low fractional shortening (<25%) or low left ventricular out-
put (<170 mL $ kg1 $ h1) and increased need for cardiotropes and demonstrated a trend toward an impaired
stress–velocity relationship. Neonates with impaired left ventricular systolic performance were more likely to re-
quire cardiotropes and have low systolic arterial pressure, increased heart rate, and abnormal base deficit.
Conclusion: Patent ductus arteriosus ligation is sometimes associated with impaired left ventricular systolic per-
formance, which is most likely attributable to altered loading conditions. Neonates weighing 1000 g or less are at
increased risk of impaired left ventricular systolic performance, which might relate to maturational differences
and decreased tolerance to altered loading conditions. (J Thorac Cardiovasc Surg 2010;140:150-7)Earn CME credits at
http://cme.ctsnetjournals.org
The hemodynamically significant ductus arteriosus (HSDA)
is a common problem in premature infants that can lead to
neonatal morbidity as a result of pulmonary overcirculation
or systemic hypoperfusion.1-3 Failure of medical interven-
tion occurs in 20% to 30% of extremely low-birth-weight
infants, necessitating surgical intervention,4-6 although rates
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The Journal of Thoracic and Cardiovascular Surgstrated that ligation of the patent ductus arteriosus (PDA)
is complicated by hemodynamic instability and a need for
escalation in respiratory support.7,8 We identified a relation-
ship between age at ligation and risk of postligation cardiac
syndrome, which is characterized by oxygenation failure
and systolic hypotension requiring cardiotropic support
within 8 to 12 hours of intervention.8 PDA ligation in prema-
ture baboons resulted in impaired left ventricular (LV) sys-
tolic performance and ventilation failure, which coincided
with an increase in measured systemic vascular resistance
(SVR).9 Because the neonatal myocardium is less tolerant
of increased afterload, the risk of impaired LV systolic per-
formance and clinical deterioration might be greater in more
immature infants.10
Recently, impaired myocardial performance after PDA
ligation, which is associated with altered preload, was
demonstrated in neonates,11 but echocardiographic analysis
was not performed during the period of clinical instability.
The a priori primary aim of this study was to characterize
the effect of PDA ligation on LV systolic performance and
loading conditions. We hypothesized that PDA ligation is
associated with impairment in LV performance coinciding
with altered cardiac loading conditions during clinical
deterioration.ery c July 2010
Abbreviations and Acronyms
ANOVA ¼ analysis of variance
ESWS ¼ end-systolic wall stress
FS ¼ fractional shortening
HSDA ¼ hemodynamically significant ductus
arteriosus
IQR ¼ interquartile range
LA/Ao ¼ ratio of left atrium to aortic root
dimension
LV ¼ left ventricular
LVEDD ¼ left ventricular end-diastolic dimension
LVESD ¼ left ventricular end-systolic dimension
LVET ¼ left ventricular ejection time
LVE-VR ¼ left ventricular exposed vascular
resistance
LVO ¼ left ventricular output
MAP ¼ mean arterial pressure
mVCFc ¼ mean velocity of circumferential fiber
shortening
PDA ¼ patent ductus arteriosus
SAP ¼ systolic arterial pressure
SVC ¼ superior vena cava
SVR ¼ systemic vascular resistance
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We performed a prospective observational study performed at an out-
born quaternary neonatal intensive care unit. The primary objective of
this study was to characterize the effects of PDA ligation on LV systolic per-
formance and loading conditions in premature infants. The a priori second-
ary objectives were to investigate the effect of these echocardiographic
changes on cardiorespiratory well-being and determine whether neonates
weighing less than 1000 g were at greater risk of impaired myocardial per-
formance.Study Population
Premature infants born at less than 32 weeks’ gestation who underwent
PDA ligation at the Hospital for Sick Children, Toronto, Ontario, Canada,
between January and November 2005 were eligible for enrollment. Neo-
nates were considered suitable for surgical ligation after failure of medical
management or when indomethacin was contraindicated. The study popula-
tion included neonates referred from 2 neighboring inborn tertiary care units
and neonates from the study site, which is an outborn center. All patients
were transported to the surgical site by a dedicated neonatal transport
team at least 6 hours before the procedure. Newborns with congenital heart
disease, except a patent foramen ovale, were excluded. The study was
approved by the institutional research ethics board. Parental consent was
obtained for all enrolled babies.Diagnosis of an HSDA
An HSDA was clinically suspected when a murmur was associated with
a wide pulse pressure, precordial activity, and cardiorespiratory instability
or in the absence of a murmur caused by early-onset hypotension or oxygen-
ation failure. Two-dimensional echocardiographic analysis was performed
to quantify ductal characteristics before deciding on surgical ligation. An
HSDA was defined by a transductal diameter of greater than 1.5 mm withThe Journal of Thoracic and Caunrestrictive (<1.0 m $ s1) left-to-right tranductal flow and clinical symp-
toms of pulmonary overcirculation, systemic hypoperfusion, or both.Medical Treatment
The usual medical practice consisted of fluid restriction and 2 courses of
high-dose (0.2 mg $ kg1) indomethacin administered at 12-hour intervals
unless adverse effects occurred or there was a contraindication to treatment.
Prophylactic indomethacin (0.1 mg $ kg1) was used for the first 3 days of
life at one center.
Preoperative Stabilization
All patients had a hemoglobin level of greater than 100 g $ L1, a platelet
count of greater than 100,000/mm3, and an international normalized ratio of
less than 1.0 before surgical intervention. All neonates on high-frequency
modes of ventilation were successfully switched to conventional ventila-
tion, and enteral feeds were withheld for at least 6 hours before surgical in-
tervention.
Surgical Procedure
The procedure was performed in the operating room by a cardiovascu-
lar surgeon. All neonates were anesthetized with fentanyl and either ro-
curonium or pancuronium. Newborns were placed in the right lateral
position, and a left midaxillary incision was made. The left lung was
retracted, and the ductus arteriosus was mobilized. The ductus was then
either ligated with sutures or metal clips according to the surgeon. An in-
tercostal drain was placed when there was a suspicion of pneumothorax.
Fluid boluses (0.9% saline) were administered for hypotension or exces-
sive fluid losses.
Routine Postoperative Care
All neonates were transferred back to the neonatal intensive care unit and
commenced on a morphine or fentanyl infusion. This was subsequently ta-
pered over 6 to 24 hours depending on an objective assessment of pain using
the Premature Infant Pain Profile score.12 A chest radiograph was obtained
for all babies 1 hour after the procedure to assess lung inflation and exclude
air leaks. Hypotension was defined by a mean arterial pressure (MAP) of
less than that for corrected gestational age or a systolic arterial pressure
(SAP) of less than the third percentile for corrected gestational age. Treat-
ment decisions for cardiovascular instability were at the discretion of the at-
tending neonatologist, who remained blind to all echocardiographic data. A
fluid bolus of 10 mL $ kg1 0.9% saline or cardiotropes was initially admin-
istered. The usual practice was to start with an infusion of dobutamine, do-
pamine, or both at 5 to 10, which was titrated to a maximum of 20 mg $ kg1
$ min1, and escalate to an infusion of epinephrine, if necessary. Replace-
ment steroid therapy with 1 to 2 mg $ kg1 hydrocortisone was considered
after failure of 2 cardiotropic agents.
Data Collection
Baseline neonatal characteristics, preligation neonatal morbidities, clin-
ical and echocardiographic characteristics of the HSDA, dosage and dura-
tion of indomethacin treatment, and surgical details were reviewed.
Physiologic indices of cardiorespiratory stability (eg, systolic and diastolic
arterial pressures and oxygen saturation) were extracted from the electronic
patient chart preoperatively and at 1, 4, 8, 12, and 24 hours after the proce-
dure. MAP was measured directly by using a transducer connected to an in-
dwelling catheter in the majority of patients because it is standard care at our
institution to place a peripheral arterial line. In cases in which this was not
feasible, noninvasive cuff readings were obtained by using the oscillometric
method. Mean airway pressure (MAP) and fraction of inspired oxygen ox-
ygenation index were monitored at these time points, as surrogates of the
degree of respiratory support. The need for fluid boluses, blood transfusion,
and cardiotropes was documented.rdiovascular Surgery c Volume 140, Number 1 151
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1. Two-dimensional echocardiographic analysis was performed preoperatively
(within 2 hours of intervention) and at 1, 8, and 24 hours after surgical intervention.
Echocardiographic analysis was performed by a single operator (LS) who was
trained in functional echocardiographic methodology under the direct supervision
of the principal investigator (PJM). All evaluations were performed by using the
Vivid 7 Advantage cardiovascular ultrasound system (GE Medical Systems, Mil-
waukee, Wis) with a 7.5-MHz high-frequency phased array transducer probe that
allowed image acquisition at a rate of 400 frames per second. All images were saved
to an optical disk for offline analysis.
2. For echocardiographic measurements/calculations, standard M-mode, 2-dimen-
sional, pulsed-wave, continuous-wave, and color Doppler transthoracic echocar-
diographic analyses were performed.
For ductal assessment, baseline transductal diameter and flow pattern
were calculated according to published methods.13
For LV systolic performance, left ventricular end-diastolic dimension
(LVEDD), left ventricular end-systolic dimension (LVESD), and posterior
wall thickness at end-diastole and peak systole were measured and averaged
over 5 cycles. Left ventricular ejection time (LVET) was assessed by using
M-mode tracings of aortic valve motion and measured from valve opening
to closing. This was corrected to heart rate by dividing by the square root of
the R-R interval (LVETc). LV fractional shortening (FS) was calculated as
follows: (LVEDDLVESD)/LVEDD. The mean velocity of circumferen-
tial fiber shortening (mVCFc), a more accurate measure of contractility, was
calculated as follows: FS/LVETc. Left ventricular output (LVO) was calcu-
lated as follows: [(Velocity time integral) 3 (Heart rate) 3 (Aortic cross-
sectional area)] indexed to body weight.14 The stress–velocity relationship
is a preload-independent, afterload-adjusted method of assessing LV con-
tractility.15 The relationship between end-systolic wall stress (ESWS) and
mVCFc is evaluated according to linear regression methods. The slope of
the regression line and linear intercept of the y-axis were then estimated
for each time point. This relationship has been studied in full-term10 and pre-
mature infants both with and without a PDA.16 mVCFc (circ/seconds) was
calculated as follows: LV FS/LVETc. ESWS (g/cm2) was calculated as fol-
lows: [1.35 3 (MAP) 3 (LVESD)]/[4 3 (HES) 3 (1þHES/LVESD)],
where 1.35 is the conversion factor from millimeters of mercury to grams
per square centimeter, and HES is the LV posterior wall thickness at end
systole. MAP was used because it has been shown to provide a reasonable
estimate of LV end-systolic pressure in children.10 Because of the unreli-
ability of LVO as an estimate of systemic blood flow in the presence of
an HSDA, superior vena caval (SVC) flow was also calculated as follows:
[(Velocity time integral) 3 (Heart rate) 3 (SVC cross-sectional area)] in-
dexed to body weight, as described by Kluckow and Evans, although there
are no published norms for this postnatal age group.
LV preload was estimated from the LVEDD and the ratio of left atrium to
aortic root dimension (LA/Ao ratio).
LV afterload is subject to the influence of vascular resistance; however,
because the left ventricle is exposed to both pulmonary and systemic vascu-
lar beds before ductal closure, we calculated left ventricular exposed vascu-
lar resistance (LVE-VR) as a surrogate representation of the cumulative
resistance. LVE-VR (dynes/s/cm5) was calculated as follows: (MAPRight
atrial pressure)/LVO, with an estimated right atrial pressure value of 5 mm
Hg. ESWS (g/cm2) was also calculated as described above.
Pulmonary hemodynamics were assessed by calculating right ventricular
systolic pressure [43 (Peak tricuspid regurgitant jet velocity)2þ5] and right
ventricular output [(Velocity time integral)3 (Heart rate)3 (Pulmonary ar-
tery cross sectional area)] indexed to body weight.
Arterial blood gas testing was performed at baseline and 1, 8, and 24
hours after intervention.
Outcome Measures
The primary outcome studied was LV systolic performance, which was
characterized by indices of LV contractility (FS and mVCFc/ESWS rela-
tionship) and systemic blood flow (LVO). Indicators of impaired LV sys-152 The Journal of Thoracic and Cardiovascular Surgtolic performance included an LV FS of less than 25%,17,18 an LVO of
less than 170 mL $ kg1 $ min1,17,19 an SAP of less than the third percen-
tile,20 or a significant change from baseline in the slope of the mVCFC/
ESWS regression line. Secondary outcomes included LV preload and after-
load, heart rate, systolic and diastolic arterial pressure, arterial pH, and base
deficit.
Statistics
Descriptive statistics were used for neonatal demographics and charac-
teristics of the ductus arteriosus, LV systolic performance, and perioperative
hemodynamics. Repeated-measures analysis of variance (ANOVA) was
used to analyze serial changes in indices of LV systolic performance, pre-
load, and afterload. Linear regression analysis was used to determine the
significance of correlations between mVCFc and ESWS. Subgroup analysis
was performed to compare neonates weighing less than 1000 g with those
weighing more than 1000 g at surgical intervention because we speculated
that smaller infants were at greatest risk of postoperative cardiorespiratory
instability. Specifically, a comparison of the frequency of critical indicators
of LV dysfunction (eg, LV FS<25%, LVO<170 mL $ kg1 $ min1, and
SAP less than the third percentile) was made between groups. Continuous
variables were compared by using the t test or Mann–Whitney U test, re-
spectively. Fisher exact and c2 tests were used to analyze categorical vari-
ables. A comparison of the mVCFc/ESWS relationship was made at each
respective time point. Analysis of covariance was used to compare the
slopes and intercepts of the regression lines with baseline values. Subgroup
analysis was performed between neonates with postoperative impaired LV
systolic performance (LV FS<25% or LVO<170mL $ kg1 $min1) at any
of the postoperative evaluation time points versus normal LV systolic per-
formance to determine the clinical effect of these echocardiographic
changes. We compared clinical markers suggestive of a low cardiac output
state between groups and chose to focus on the first 8 hours after surgical
intervention before the commencement of cardiotropic support. The average
values for heart rate, arterial pressure, oxygen requirement, base deficit, and
LVO were calculated. Univariate logistic analysis was also performed to
identify predictors of LV FS of less than 25% and LVO of less than 170
mL $ kg1 $ min1. Data are presented as means  standard deviations or
medians and interquartile ranges (IQRs). In this pilot study a convenience
sample size of 40 patients was chosen.
RESULTS
Sixty-five neonates were referred for PDA ligation during
the study period; parental consent was obtained for 46
babies. The mean gestational age and weight at birth were
25.3  1.4 weeks and 777  212 g, respectively. The aver-
age age at echocardiographic diagnosis of HSDA was 13.8
 8.8 days. Indomethacin was administered to 86.9% pa-
tients, with patients receiving an average of 5.9 2.7 doses.
The mean postnatal age and weight at surgical intervention
were 28.5  11.3 days and 1058  272 g, respectively.
Transductal diameter was 3.6  0.4 mm, with unrestrictive
left-to-right transductal flow.
Postoperative Cardiorespiratory Stability
The postoperative period was characterized by a transient
reduction in body temperature, decreased heart rate, and in-
creased diastolic arterial pressure oxygen requirement and
oxygenation index (Table 1). A postoperative increase in re-
spiratory support was seen in 22 (48%) patients. Three pa-
tients required postoperative high-frequency oscillation, all
of whom weighed less than 1000 g and had impaired LVery c July 2010
TABLE 1. Perioperative cardiorespiratory physiology and degree of respiratory support in neonates undergoing PDA ligation
Baseline 1 h 4 h 8 h 12 h 24 h P value
Heart rate (beats/min) 154 (148–163) 146 (139–161) 144 (135–155)* 148 (142–157) 150 (140–161) 150 (142–160) <.001
Temperature (C) 36.8 (36.6–37) 36.4 (36–36.9) 36.5 (36.4–36.8)* 36.7 (36.4–36.9) 36.8 (36.5–37.1) 36.8 (36.7–37) <.001
Systolic AP (mm Hg) 55 (51–64) 58 (51–63) 54 (48–61) 54 (47–63) 53 (49–59) 57 (54–63) .09
Diastolic AP (mm Hg) 26 (23–31) 34 (29–38)* 32 (29–37)* 32 (29–36)* 30 (26–36)* 31 (28–37)* <.001
FIO2 (%) 31 (28–40) 38 (28–50) 30 (25–40) 31.5 (26–44) 37 (30–44) 40 (34–43)* .008
Oxygenation index 7.5 (5.4–9.9) 7.4 (5.0–9.3)  8.1 (5.9–14.5)  9.7 (7.3–13.6)y .02
MAP (cm H2O) 8.8 (8–10) 9 (8–10) 8.7 (8–9) 9 (8–10) 8.9 (8–10) 9 (8.1–10) .85
pH 7.34 (7.29–7.37) 7.36 (7.31–7.41) 7.32 (7.24–7.41) 7.31 (7.27–7.37) 7.29 (7.27–7.34) 7.32 (7.29–7.36) .048
PaCO2 (mm Hg) 66 (49–61) 50 (41–63) 55.5 (41–63) 56 (49–63) 59.5 (52–64) 50 (41–63) .14
Base deficit 3 (1 to 6) 3 (0 to 4.5) 1 (2.8 to 2.7) 2 (0.5 to 4.5) 1.5 (1.5 to 3.5) 1 (1.3 to 3) .16
Data are presented as medians (ranges). PDA, Patent ductus arteriosus; AP, arterial pressure; FIO2, fractional inspired oxygen; MAP, mean airway pressure. *P< .05. yP< .05 vs
1 hour.
McNamara et al Congenital Heart Diseasesystolic performance before the transition. Perioperative car-
diovascular support included crystalloid support (n ¼ 27,
45%), red blood cell transfusion (n¼ 2, 4.3%), cardiotropic
support (n ¼ 8, 17.4%), and hydrocortisone (n ¼ 2, 4.3%)
for cardiotrope-resistant shock. The median time for com-
mencement of cardiotropic support was 10 hours (IQR,
6–12 hours).C
H
DPostoperative Echocardiographic Analysis
LV systolic performance. PDA ligation was associated
with impaired LV systolic performance, as evident by a re-
duction in FS (Table 2) and mVCFc (P< .001, ANOVA;
Figure 1 and Table 2) that was greatest 8 hours after surgical
intervention. A significant decrease in LVO (P< .001, AN-
OVA) and SVC flow index (P ¼ .001, ANOVA) occurred,
which was also maximal at 8 hours. An inverse correlation
was identified between the ESWS and mean velocity of cir-
cumferential fiber shortening (stress–velocity relationship),
but there were no differences in the slope or intercept
values between preoperative and postoperative time points
(Table 3).
LV preload/afterload. Amarked reduction in LVEDD and
the LA/Ao ratio (P< .001, Table 2) was identified, paralle-TABLE 2. Perioperative echocardiographic characteristics of neonates un
Baseline 1
LA/Ao ratio 1.7  0.2 1.3 
LVEDD (mm) 1.6 (1.4–1.8) 1.3 (1.1
LVESD (mm) 0.9  0.2 0.9 
LVPWD (mm) 0.5 (0.4–0.6) 0.5 (0.4
RVSP (mm Hg) 7.9 (6.5–12.4) 7.4 (6.7
LV FS (%) 40 (37–45) 32 (27–
SVC flow index (mL $ kg1 $ min1) 201  41 164 
RV output (mL $ kg1 $ min1) 692 (498–1084) 396 (324
LV output (mL $ kg1 $ min1) 509 (400–542) 247 (192
mVCFc (circ/s) 1.6  0.4 1.3 
ESWS (g/cm2) 21.6 (18.1–30.7) 21.1 (14.
Data are presented as means  standard deviations or medians (ranges). PDA, Patent du
dimension; LVESD, left ventricular end-systolic dimension; LVPWD, left ventricular poste
cava; RV, right ventricular; LV, left ventricular; mVCFc, mean velocity of circumferential fi
The Journal of Thoracic and Caling the changes in LV systolic performance. PDA ligation
was followed by an early and sustained increase in LVE-
VR (P<.001, Figure 2), but there was no change in ESWS.
Pulmonary hemodynamics. There were no changes in
right ventricular systolic pressure; however, a significant
decrease in right ventricular output occurred (P < .001,
Table 2).Comparison of Neonates Weighing Less Than 1000 g
(n ¼ 23) Versus More Than 1000 g (n ¼ 23)
Neonates undergoing surgical ligation at a weight of less
than 1000 g had lower gestational age (25 weeks [IQR, 23–
26 weeks] vs 26 weeks [IQR, 24–27 weeks], P ¼ .01) and
weight at birth (660 g [IQR, 500–820 g] vs 790 g [IQR,
555–1645 g], P ¼ .001). There were no other demographic,
duct-related, or anesthetic/surgical differences between
groups. The rates of a postoperative critically low SAP of
less than the third percentile, FS of less than 25%, and LVO
of less than 170 mL $ kg1 $ min1 were higher in neonates
weighing less than 1000 g (Table 4). There was an inverse
stress–velocity relationship in both subgroups, but there was
no difference in the slope or intercept values (Table 3). In neo-
natesweighing less than1000g, the slope of the stress–velocitydergoing PDA ligation
h 8 h 24 h P value
0.2* 1.2  0.2* 1.3  0.2* <.001
–1.4)* 1.3 (1.2–1.5)* 1.4 (1.3–1.6) <.001
0.2 0.9  0.2 1.0  0.2 .11
–0.6) 0.5 (0.4–0.6) 0.5 (0.4–0.5) .53
–12.9) 7.8 (6.6–11.7) 10 (6.8–16) .73
41)* 30 (25–36)* 33 (30–38)* <.001
37 149  35* 179  28.7 .001
–517)* 367 (278–487)* 472 (394–543)* <.001
–289)* 216 (170–345)* 318 (254–384)* <.001
0.3* 1.3  0.3* 1.3  0.3* <.001
2–26.1) 22.4 (16–28.7) 23.1 (20.1–34.2) .07
ctus arteriosus; LA/Ao, left atrium/aortic ratio; LVEDD, left ventricular end-diastolic
rior wall dimension; LV FS, left ventricular fractional shortening; SVC, superior vena
ber shortening; ESWS, end-systolic wall stress. *P< .05.
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FIGURE 1. Trends in mean velocity of circumferential fiber shortening
(mVCFc) after patent ductus arteriosus ligation. #P< .05 versus baseline,
analysis of variance.
FIGURE 2. Trends in left ventricular (LV) exposed vascular resistance af-
ter patent ductus arteriosus ligation. #P< .05 versus baseline, analysis of
variance.
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Drelationship at 8 hours trended (P ¼ .07) toward significance
when compared with the preoperative value. In the subgroup
of neonates weighing more than 1000 g, there were no differ-
ences in either the slope or intercept between preoperative and
postoperative stress–velocity relationship values.
Comparison of Neonates With Impaired Versus
Normal LV Performance
For more information, see Table 5. Although neonatal de-
mographics and ductal characteristics were comparable be-
tween groups, weight at surgical intervention was lower in
neonates with low LVO. There were no differences in neo-
natal characteristics or amount of perioperative sedation/an-
algesia between groups. Neonates with impaired LV systolic
performance had a higher heart rate and lower SAP and were
more likely to have a higher base deficit in the first 8 hours
after intervention. In addition, a higher proportion of these
patients were treated with cardiotropic support.TABLE 3. Stress–velocity relationship for all patients (neonates
weighing 1000 g and>1000 g)
Baseline 1 h 8 h 24 h
mVCFc/ESWS (all neonates)
Slope 0.01 0.01 0.02 0.01
Intercept 1.86 1.76 1.68 1.7
R2 0.39 0.48 0.6 0.41
mVCFc/ESWS (<1000 g)
Slope 0.015 0.013 0.03* 0.013
Intercept 1.83 1.73 1.94 1.7
R2 0.36 0.37 0.65 0.37
mVCFc/ESWS (>1000 g)
Slope 0.01 0.02 0.01 0.02
Intercept 1.93 1.17 1.37 1.12
R2 0.46 0.6 0.6 0.53
mVCFc, Mean velocity of circumferential fiber shortening; ESWS, end-systolic wall
stress. *P< .05 versus the x-axis (zero slope).
154 The Journal of Thoracic and Cardiovascular SurgPredictors of LV Dysfunction
Univariate analysis was performed to investigate any rela-
tionship between preligation or early postoperative factors
and FS of less than 25% and LVO of less than 170 mL $
kg1 $ min1 at 8 hours. Variables tested included clinical
(birth weight, gestational age, preoperative diuretic or car-
diotrope treatment, and age and weight at surgical interven-
tion) and echocardiographic (transductal diameter, LA/Ao
ratio, LVEDD, FS, mVCFc, LVO, SVC flow, ESWS, and
LVE-VR at baseline and 1 hour) factors and postoperative
need for cardiotropes. Only weight at intervention
(P ¼ .04) was associated with FS of less than 25%, but im-
portant trends for baseline LVEDD (P ¼ .05) and 1-hour
ESWS (P ¼ .06) were noted. Preoperative LVEDD
(P ¼ .04) and SAP (P ¼ .002) values were associated with
LVO of less than 170 mL $ kg1 $ min1.
DISCUSSION
PDA ligation is associated with major adaptive changes in
pulmonary and systemic hemodynamics leading to cardiore-
spiratory instability. We identified impaired LV systolic per-
formance and low LVO in a proportion of premature infants
after surgical intervention. These changes temporally coin-
cided with both increased LV exposed vascular resistance
and decreased preload,which suggests that alteredmyocardial
loading conditionsmight be responsible for the cardiovascular
deterioration. The effect of these changes was greatest in neo-
nates weighing less than 1000 g, whose rate of cardiotropes
was 30%. The clinical course and rate of cardiovascular sup-
port in our cohort is comparable with published data.7
PDA Ligation and LV Dysfunction
PDA ligation was associated with a reduction in LV FS
and mVCFC. In a preterm baboon model LV FS was shown
to deteriorate 6 to 12 hours after surgical intervention,ery c July 2010
TABLE 4. Comparison of numbers of neonates weighing<1000 g
versus those weighing >1000 g with impaired left ventricular
contractility and low cardiac output before (preoperative) and 24
hours after (postoperative) surgical intervention
<1000 g (n ¼ 23) >1000 g (n ¼ 23)
Preoperative period (<6h before intervention)
Systolic AP< third
percentile, n (%)
1 (4) 0 (0)
LVO (mL $ kg1 $ min1) 475.5  139.2 484.8  158.6
FS (%) 41.6  8.0 41.7  5.6
Transductal diameter (cm) 0.29  0.05 0.31  0.07
Postoperative period (24-h time period after intervention)
Systolic AP< third
percentile, n (%)
8 (35)* 1 (4)
LVO<170 mL $ kg1 $
min1, n (%)
7 (30)* 1 (4)
FS<25%, n (%) 7 (30)* 1 (4)
Volume>10 mL/kg, n (%) 16 (70) 12 (52)
Blood transfusion, n (%) 1 (4) 1 (4)
Cardiotropes, n (%) 7 (30)* 1 (4)
Hydrocortisone, n (%) 1 (4.3) 3 (13)
FIO2 increase>20%, n (%) 14 (61)* 6 (26)
Data are presented as frequencies (percentages of total) where relevant. AP, Arterial
pressure; LVO, left ventricular output; FS, fractional shortening; FIO2, fractional in-
spired oxygen. *P< .05 versus neonates weighing more than 1000 g.
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Dcoinciding with a temporal increase in measured SVR.9 We
identified a similar increase in LV exposed vascular resis-
tance, coinciding with both impaired LV systolic perfor-
mance and clinical deterioration. The left ventricle is
exposed to the low-resistance pulmonary circuit in the pres-
ence of a patent ductus.20 Normalization of these conditions
will occur after PDA ligation, leading to a net increase in
vascular resistance, which might affect LV loading condi-
tions. We made the assumption that the calculated LV ex-TABLE 5. Comparison of neonatal demographics and morbidities, chara
postoperative abnormal versus normal LV performance
Characteristic Abnormal LV performance (n ¼
Gestation at birth (wk) 25 (24–26)
Birth weight (g) 700 (650–948)
PDA diagnosis (d) 4 (2–5)
Transductal diameter (mm) 2.9 (3.6–3)
Indomethacin (doses) 6 (0–9)
Age at ligation (d) 27  9.3
Weight at ligation (g) 891  161
Postoperative status (n)
Heart rate (1–8 h) 159 (143–162)
Respiratory rate (1–8 h) 45  9.3
FIO2 (1–8 h;%) 41  14.2
Systolic AP (1–8 h; mm Hg) 44  7.9
Diastolic AP (1–8 h; mm Hg) 32.9  6.3
Oxygenation index (1–8 h) 11.8 (7.4–13.1)
Base deficit<4.0 (1–8 h; n) 5 (56%)
Postoperative cardiotropes, n 6 (50%)
Data are presented as means  standard deviations, medians (interquartile ranges), or freq
ventricular; FIO2, fractional inspired oxygen; AP, arterial pressure.
The Journal of Thoracic and Caposed vascular resistance was a surrogate of the resistance
the LV sees in the presence of a ductus. This assumption
is limited because to accurately calculate this value, one
would to have to apply the following formula for resistance
circuits in parallel: Total resistance¼ 1/(1/R1þ1/R2), where
R1 is SVR and R2 is the sum of peripheral vascular resis-
tance and ductus arteriosus resistance. Despite these limita-
tions, the magnitude of the change is likely to be important
for a number of reasons. First, although ductal resistance
cannot be measured in neonates, it is probably relatively
low because of size and laminar flow change and unlikely
to account for a 3-fold order of magnitude change in mea-
sured resistance. Second, postligation vascular resistance is
above the normal range for human subjects (900–1200
dynes $ s1 $ cm5). Finally the increase measured resistance
is consistent with a previous report in human primates.9
Previous studies have failed to demonstrate any relation-
ship between changes in LV systolic performance and after-
load,21,22 although the study by Noori and colleagues11
suggested LV loading conditions to be important. Kimball
and associates21 performed comprehensive echocardio-
graphic assessments on 14 premature infants and concluded
that although vascular resistance increased, myocardial per-
formance did not change. Noori and colleagues11 studied 23
neonates and identified postoperative reductions in LVO and
myocardial performance index, a surrogate of global myo-
cardial function, which they attributed to decreased LV pre-
load. These findings are important; however, both studies
have some important limitations. First, the sample size is
small and, in the latter study, includes a mixture of retrospec-
tive and prospective patients. Second, postoperative echo-
cardiographic analysis was performed within 2 hours of
intervention but not again until after 24 hours, missing thecteristics of the PDA, and status at surgical ligation in neonates with
12) Normal LV performance (n ¼ 37) P value
25 (24–26) .75
730 (640–787) .98
4 (3–7) .95
3 (2.4–3.5) .37
6 (0–10) .44
29.9  12.1 .4
1096  283 .04
144 (141–149) .05
35  8.3 .06
35  11.5 .3
51.1  9.5 .04
34.2  7.5 .6
7.7 (5.6–10.8) .1
2 (5.4%) .007
2 (5%) .001
uencies (percentages of total) where relevant. PDA, Patent ductus arteriosus; LV, left
rdiovascular Surgery c Volume 140, Number 1 155
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Dtime of clinical deterioration. We did not assess global myo-
cardial performance, but we did identify a significant de-
crease in LVO, right ventricular output, and SVC flow.
The changes in LVO were also demonstrated in 21 neonates
studied by Lindner and coworkers.22 The finding of low
LVO and impaired LV performance is clinically relevant be-
cause these patients had higher heart and respiratory rates
and lower SAPs and were more likely to have an abnormal
base deficit in the first 8 hours. In addition, a higher propor-
tion of these patients subsequently required treatment with
cardiotropic agents.
The changes in pulmonary and systemic blood flow were
temporally associated with impaired LV systolic perfor-
mance. The nature of altered LV systolic performance is
likely to relate to cardiac loading conditions, although deter-
mining the relative contribution of each is difficult. PDA li-
gation was associated with both a decrease in LVEDD and
LA/Ao ratio, surrogates of left heart preload, and increased
LV exposed vascular resistance. It is not possible to prove
whether the changes in preload are causal, although the mag-
nitude of the reduction suggests they are likely to have some
effect. We did not identify any major overall change in the
stress–velocity relationship, which is surprising in the con-
text of increased vascular resistance. The maintenance of
wall stress at low levels might be explained by low end-sys-
tolic dimension, suggesting wall stress to be also preload de-
pendant,11,21 therein raising doubt over its reliability in this
setting. The low number of patients requiring cardiotropes
might have biased against detecting any measurable change.
Nevertheless, the slope of the line at 8 hours, particularly in
neonates weighing less than 1000 g (0.03), is much higher
than normative data for healthy premature infants of less
than 30 weeks’ gestation (0.004 to 0.007) and those
with a severely low systemic blood flow state (0.01),22 sug-
gesting an effect on myocardial performance.
LV Dysfunction and Immaturity
Previously, we have shown that patients who undergo
PDA ligation at an earlier age are at greatest risk of postop-
erative hemodynamic instability.8 There is also evidence
that gestational age and weight at birth are predictive of
need for vasopressor treatment.7 Developmentally, the im-
mature myocardium has been shown to exhibit a higher
basal contractile state and a greater sensitivity to afterload
changes.10,23,24 The intolerance of the immature myocar-
dium to increased afterload might be attributable to differ-
ences in myofibrillar architecture or immaturity of receptor
development or regulation.25 In this study a higher propor-
tion of neonates weighing less than 1000 g had low FS of
less than 25% and low LVO of less than 170 mL $ kg1 $
min1 within 8 hours of intervention, suggesting a develop-
mental effect. Interestingly, the slope of the stress–velocity
relationship was also highest in neonates weighing less
than 1000 g at 8 hours and demonstrated an interesting trend156 The Journal of Thoracic and Cardiovascular Surgwhen compared with the preoperative slope. This suggests
that the study might have been underpowered to determine
a true difference. On univariate analysis, an association be-
tween weight at intervention and FS of less than 25% at 8
hours was identified. Preoperative LVEDD and SAP values
were associated with an LVO of less than 170 mL $ kg1 $
min1 at 8 hours. These factors might be important consider-
ations for perioperative monitoring.
Clinical Relevance of LV Dysfunction
The magnitude of the changes in heart rate, arterial pH,
ventilation requirements, and fraction of inspired oxygen
oxygenation index were minimal, and numbers of patients
requiring cardiotropes were low in the overall study popula-
tion. This is not an unexpected finding because the study
population includes older patients who were clinically well
in the postoperative period with minimal echocardiographic
changes and those with cardiorespiratory compromise and
echocardiographic evidence of low LVO. Nevertheless, it
is meritorious and of benefit to health care professionals
who are managing these patients to be aware of the clinical
and echocardiographic changes in both patient subgroups in
monitoring these patients postoperatively.
Neonates with impaired LV performance had lower SAPs
and higher rates of abnormal base deficit and need for car-
diotropes. The physiologic effects in a preterm baboon
model of PDA ligation included oxygenation failure in the
first 72 hours, with an improvement in lung compliance
and pulmonary hemodynamics by 1 week after the proce-
dure.26 We have not yet addressed the long-term respiratory
outcomes in this study. The recent articles by Kabra and co-
workers5 and Chorne and associates4 highlight associations
between PDA ligation and increased risk of bronchopulmo-
nary dysplasia, severe retinopathy of prematurity, and neu-
rosensory impairment. Whether PDA ligation is causal or
is merely a surrogate marker of a biological state with an in-
creased risk of adverse outcome remains unknown. The in-
creased risk of clinical deterioration in neonates with
impaired LV systolic performance further emphasizes the
need to characterize any possible relationship of this period
of instability to important neonatal outcomes. Early identifi-
cation of patients at increased risk of cardiorespiratory com-
promise requires prospective evaluation.
Limitations
It is possible that the administration of crystalloid therapy
or cardiotropic agents confounded the final echocardio-
graphic evaluation; however, earlier studies (1 and 8 hours)
were performed before the commencement of any cardio-
tropes. The contribution of anesthetic agents to the hemody-
namic changes is an important consideration, although it is
difficult to quantify in the absence of a control group. An an-
esthetic effect appears less likely because it would be ex-
pected to present much earlier in the postoperative period.ery c July 2010
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mance did not receive a higher amount of anesthesia. Echo-
cardiographic measurements are subject to interobserver or
intraobserver variability of 10% to 15%, but the magnitude
of the hemodynamic changes seen suggest them to be real.
Third, the persistently high ratio of right ventricular out-
put/LVO after PDA ligation is an unexpected finding. This
most likely relates to ongoing left-to-right atrial shunting,
but unfortunately, we did not document the size of the patent
foramen ovale/atrial septal defect. In addition, it is not pos-
sible to quantify the magnitude of the flow or pressure differ-
ential across it, which might have provided valuable
information regarding left atrial pressure or LV end-diastolic
pressure. The fact that SVC flow accounted for a higher pro-
portion of right ventricular output after PDA ligation might
also be important. Neonates with an HSDA might have
reversed or absent cerebral blood flow, as estimated by
means of pulsed-wave Doppler scanning, which is restored
after PDA ligation. These changes might also relate to oper-
ator-dependant factors because echocardiography-based
estimations of cardiac output are limited4; however, invasive
estimates are not possible in extremely low-birth-weight in-
fants. Our study might have been underpowered to clearly
determine the effect of afterload, as evidenced by the low
number of neonates who required cardiotropes. Finally,
there might be important and relevant changes in diastolic
performance that were not addressed in this study.CONCLUSION
The postoperative course after PDA ligation is variable,
but in some patients oxygenation difficulty and hemody-
namic instability might ensue. Neonates with postoperative
impairment in LV systolic performance, particularly those
weighing less than 1000 g, were more likely to have low
SAP and abnormal base deficit and need cardiotropes. These
changes in myocardial performance are likely to be a conse-
quence of altered loading conditions because they paralleled
major alterations in LV exposed vascular resistance and pre-
load, which have important implications when considering
the most appropriate cardiovascular intervention. We identi-
fied a nonsignificant trend toward a change from in the pre-
load-independent, afterload-adjusted method of assessing.
LV contractility by 8 hours in neonates weighing less than
1000 g. The purpose of this study was not to challenge the
decision to perform a PDA ligation but to characterize im-
portant changes in cardiovascular physiology. These might
facilitate earlier identification of at-risk neonates and more
focused postoperative intensive care.References
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